Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
2.420
-0.120 (-4.72%)
At close: Sep 12, 2025, 4:00 PM EDT
2.430
+0.010 (0.41%)
After-hours: Sep 12, 2025, 7:46 PM EDT
Eledon Pharmaceuticals Market Cap
Eledon Pharmaceuticals has a market cap or net worth of $144.91 million as of September 12, 2025. Its market cap has increased by 27.77% in one year.
Market Cap
144.91M
Enterprise Value
38.15M
1-Year Change
27.77%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since May 11, 2017, Eledon Pharmaceuticals's market cap has increased from $44.66M to $144.91M, an increase of 224.48%. That is a compound annual growth rate of 15.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 144.91M | -41.12% |
| Dec 31, 2024 | 246.13M | 465.07% |
| Dec 29, 2023 | 43.56M | 38.87% |
| Dec 30, 2022 | 31.37M | -50.29% |
| Dec 31, 2021 | 63.09M | -72.98% |
| Dec 31, 2020 | 233.47M | 3,004.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |